Cargando…

Sitagliptin: Is It Effective in Routine Clinical Practice?

Aim. The present study was conducted to determine the glycaemic effects of sitagliptin in type 2 diabetes patients. Methods. Data was collected from patient medical records of a major teaching hospital in Malaysia, from 2009 to 2012. Glycated hemoglobin (HbA(1c)) values prior to and up to 12 months...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohan Dallumal, Rita, Chua, Siew Siang, Wu, David Bin-Chia, Vethakkan, Shireene Ratna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451333/ https://www.ncbi.nlm.nih.gov/pubmed/26089904 http://dx.doi.org/10.1155/2015/950571

Ejemplares similares

Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

Why do some people with type 2 diabetes who are using insulin have poor glycaemic control? A qualitative study
por: Tong, Wen Ting, et al.
Publicado: (2015)

Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Retrospective Study
por: Zaman Huri, Hasniza, et al.
Publicado: (2014)

A Case of Severe Lactation Ketoacidosis in a Nondiabetic Mother on a Ketogenic Diet
por: Borhan, Marisa Khatijah, et al.
Publicado: (2023)

Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Syed Ikmal, Sharifah Intan Qhadijah, et al.
Publicado: (2013)

PRKAR1A-negative familial Cushing’s syndrome: two case reports
por: Lim, Lee Ling, et al.
Publicado: (2015)

Relationship of glycated hemoglobin, and fasting and postprandial hyperglycemia in type 2 diabetes mellitus patients in Malaysia
por: Lim, Lee Ling, et al.
Publicado: (2016)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

ODP173 Control of Alpelisib-Induced Hyperglycemia With DPP4- Inhibitors as add on to Metformin and Insulin
por: Hee, Nicholas Ken Yoong, et al.
Publicado: (2022)

Sitagliptin, sitagliptin and metformin, or sitagliptin and amitriptyline attenuate streptozotocin-nicotinamide induced diabetic neuropathy in rats
por: Sharma, Ashish Kumar, et al.
Publicado: (2012)

ODP346 Prevalence and Predictors of Endocrinopathies Amongst Patients on Chronic Opioid Use for Non-Cancer Pain
por: Ooi, Xin Y, et al.
Publicado: (2022)

What Does SGLT2 Inhibition Add in Managing Hyponatremia Secondary to Syndrome of Inappropriate Antidiuresis (SIAD)?
por: Jalal, Fadzliana Hanum, et al.
Publicado: (2021)

Prevalence of chronic periodontitis in an obese population: a preliminary study
por: Khan, Shahrukh, et al.
Publicado: (2015)

ODP413 Impact of Gestational Weight Gain according to 2009 IOM Recommendations on Neonatal Anthropometrics in Asians: A Pilot Study from Malaysia
por: Tai, Yong Ting, et al.
Publicado: (2022)

Practical Asymmetric Synthesis of Sitagliptin Phosphate Monohydrate
por: Gao, Haoling, et al.
Publicado: (2018)

Effect of sitagliptin on proteinuria in patients with type 2 diabetes – A renoprotective effect of sitagliptin
por: Narimani, Rouhollah, et al.
Publicado: (2021)

Observational study investigating the prevalence of asymptomatic stage B heart failure in patients with type 2 diabetes who are not known to have coronary artery disease
por: Oo, Mon Myat, et al.
Publicado: (2021)

Patient Characteristics, Disease Burden, Treatment Patterns and Outcomes in Patients with Acromegaly: Real-World Evidence from the Malaysian Acromegaly Registry
por: Long Bidin, Mohamed Badrulnizam, et al.
Publicado: (2023)

Efficacy and Safety of Insulin Glargine 300 U/mL in People with Type 2 Diabetes Uncontrolled on Basal Insulin: The 26-Week Interventional, Single-Arm ARTEMIS-DM Study
por: Sethi, Bipin, et al.
Publicado: (2022)

Practice of pharmaceutical care by community pharmacists in response to self-medication request for a cough: a simulated client study
por: Loh, Pengyeow, et al.
Publicado: (2023)

Combined effects of synbiotic and sitagliptin versus sitagliptin alone in patients with nonalcoholic fatty liver disease
por: Sayari, Saba, et al.
Publicado: (2018)

Is sitagliptin effective for the treatment of COVID-19?
por: Memiş, Hasan, et al.
Publicado: (2022)

Practical, Asymmetric Route to Sitagliptin and Derivatives: Development and Origin of Diastereoselectivity
por: Gutierrez, Osvaldo, et al.
Publicado: (2015)

Sitagliptin-induced hemolysis
por: Bekur, Ragini, et al.
Publicado: (2010)

Sitagliptin-Associated Angioedema
por: Gosmanov, Aidar R., et al.
Publicado: (2012)

Additive effects of atorvastatin combined with sitagliptin on rats with myocardial infarction: a pilot study
por: Ke, Xiao, et al.
Publicado: (2017)

Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes
por: Chung, Wen Wei, et al.
Publicado: (2014)

Combination of synbiotic and sitagliptin in nonalcoholic fatty liver disease: Is it better than sitagliptin alone?
por: Cho, Yong Kyun
Publicado: (2018)

The Malaysian Medication Adherence Scale (MALMAS): Concurrent Validity Using a Clinical Measure among People with Type 2 Diabetes in Malaysia
por: Chung, Wen Wei, et al.
Publicado: (2015)

Knowledge and Attitude of University Students on Antibiotics: A Cross-sectional Study in Malaysia
por: Tiong, Ting Wei, et al.
Publicado: (2020)

Fixed drug eruption to sitagliptin
por: Gupta, Mrinal, et al.
Publicado: (2015)

The extent and barriers in providing pharmaceutical care services by community pharmacists in Malaysia: a cross-sectional study
por: Loh, Pengyeow, et al.
Publicado: (2021)

Hepatoprotective effect of sitagliptin against methotrexate induced liver toxicity
por: Abo-Haded, Hany M., et al.
Publicado: (2017)

Pancreatic Safety of Sitagliptin in the TECOS Study
por: Buse, John B., et al.
Publicado: (2017)

Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
por: Engel, S S, et al.
Publicado: (2010)

OR11-5 Early Prevalence of Neuroendocrine Dysfunction after Spontaneous Aneurysmal Subarachnoid Haemorrhage: Interim Findings from a Prospective Cohort Study
por: Chooi, Kheng Chiew, et al.
Publicado: (2019)

Rhinorrhea, cough and fatigue in patients taking sitagliptin
por: Baraniuk, James N, et al.
Publicado: (2010)

The Effectiveness of Online Cognitive Behavioral Treatment in Routine Clinical Practice
por: Ruwaard, Jeroen, et al.
Publicado: (2012)

PERS&O (PERsistent Sitagliptin treatment & Outcomes): observational retrospective study on cardiovascular risk evolution in patients with type 2 diabetes on persistent sitagliptin treatment
por: Buonaiuto, Giulia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ko605njkbuuet4u8k077tnp2rm